Literature DB >> 11519784

Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices.

M E Sangalli1, L Zema, A Maroni, A Foppoli, F Giordano, A Gazzaniga.   

Abstract

The release behavior of poorly soluble drugs (naproxen and ketoprofen) from inert (acrylic resins) and hydrophilic swellable (high-viscosity hydroxypropylmethylcellulose) tableted matrices containing betacyclodextrin (betaCD) was investigated. The results demonstrated that, in both cases, betaCD can enhance the rate of drug release. Matrices obtained from formulations in which lactose replaced betaCD were also evaluated. BetaCD in inert matrices causes a dramatic increase in the rate of drug release, higher than that promoted by lactose which merely acts as a channelling agent. This result suggests that possible in situ formation of the drug-betaCD complex. which causes an improvement in apparent drug solubility, could have a greater influence on the rate of drug release than the possible increase of water uptake by a soluble filler. Indeed, if the opposite were true, lactose would be more effective in increasing the rate of drug release than betaCD, because of its greater solubility in water. On the contrary, in the case of hydrophilic matrices, lactose proves to be much more effective in promoting drug release than betaCD. It seems that, while the bulky interaction compound can freely diffuse through water-filled pores of inert systems, its diffusion through swollen macromolecular chains of hydrophilic matrices may be hindered. This hypothesis was supported by data obtained from binary (drug/polymer) and ternary (drug/polymer/betaCD) hydrophilic matrices using a betaCD-containing dissolution media.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519784     DOI: 10.1016/s0142-9612(01)00005-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

1.  Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery.

Authors:  Reena M P Singh; Anil Kumar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2013-01-29       Impact factor: 3.246

Review 2.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

3.  Molecular cycloencapsulation augments solubility and improves therapeutic index of brominated noscapine in prostate cancer cells.

Authors:  Jitender Madan; Bharat Baruah; Mulpuri Nagaraju; Mohamed O Abdalla; Clayton Yates; Timothy Turner; Vijay Rangari; Donald Hamelberg; Ritu Aneja
Journal:  Mol Pharm       Date:  2012-04-27       Impact factor: 4.939

4.  Chitosan and β-Cyclodextrin-epichlorohydrin Polymer Composite Film as a Plant Healthcare Material for Carbendazim-Controlled Release to Protect Rape against Sclerotinia sclerotiorum (Lib.) de Bary.

Authors:  Delong Wang; Mingchen Jia; Lanying Wang; Shuang Song; Juntao Feng; Xing Zhang
Journal:  Materials (Basel)       Date:  2017-03-26       Impact factor: 3.623

5.  Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets.

Authors:  Wael Samy; Ayman Elnoby; Hanan M El-Gowelli; Nazik Elgindy
Journal:  Saudi Pharm J       Date:  2016-10-17       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.